PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2051995
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2051995
The global lab automation market is expected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, at a CAGR of 6.6%. Key factors driving the adoption of lab automation include the demand for high-throughput testing, the rise in omics research, and the need for more accurate and faster results in laboratory procedures.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Product, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Additionally, the increasing prevalence of chronic diseases is driving greater investment in research and development and a demand for faster diagnoses, further accelerating the adoption of automation in laboratories.

"The automated workstations segment accounted for the largest market share in 2025."
The automated workstations segment is expected to lead the lab automation market during the forecast period. This product line enhances laboratory workflow by offering streamlined workstations, increased precision, and improved reproducibility across various applications. Among automated workstation products, liquid-handling workstations are commonly used for high-accuracy sample and reagent transfer, which is essential for applications such as PCR, qPCR, and next-generation sequencing. Another significant subsegment is microplate readers, which enable high-throughput screening and assay quantification, thereby accelerating drug discovery and biological research. Additionally, automated ELISA systems are in high demand because they streamline the time-consuming protocols involved in immunoassays. These systems enable diagnostics and clinical laboratories to save considerable time by automating all immunoassay procedures, delivering rapid, reliable results while minimizing manual intervention. Moreover, automated nucleic acid purification systems are essential for molecular biology and genomics research, as they expedite DNA and RNA extraction and purification for subsequent applications. The growth in these subsegments reflects the lab automation market's focus on increasing efficiency and data quality, which are crucial factors in pharmaceutical, diagnostic, and research settings.
"The hospitals & diagnostic laboratories segment held the largest share of the lab automation market in 2025."
The lab automation market is segmented by end user: hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, environmental testing laboratories, forensic laboratories, and the food & beverage industry. By 2025, hospitals & diagnostic laboratories are expected to hold the largest market share. This growth is primarily driven by increasing demand for throughput, accuracy, and high-speed diagnostic solutions necessary to treat more patients who require a variety of complex tests. Automation solutions in these settings will help simplify workflows, reduce turnaround times, and enhance accuracy.
"Asia Pacific is expected to register the highest growth rate in the market during the forecast period."
The Asia Pacific region is expected to lead the growth in the lab automation market, showing the highest growth rate during the forecast period. This growth will be fueled by increased investment in healthcare infrastructure, a strong emphasis on research and development from the pharmaceutical and biotechnology industries, and a rising demand for efficient diagnostic solutions to serve the region's growing population. Additionally, advancements in artificial intelligence and robotics are helping laboratories in various sectors become more automated.
Prominent players in the lab automation market include Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMerieux (France), Hamilton Company (US), and Hudson Robotics (US).
Research Coverage
The market is organized by product, application, end user, and region. The report also discusses various factors impacting the lab automation market, including drivers, constraints, opportunities, and challenges. It offers insights into the opportunities and challenges facing stakeholders and profiles the competitive landscape of leading players. Additionally, micromarkets are further divided by examining growth trends, prospects, and how these trends contribute to the lab automation market. Revenue generation across different market segments will be forecasted, with a focus on growth in five major geographic regions.
Key Benefits of Buying this Report
This report is designed to benefit both new and existing players in the lab automation market. It provides in-depth information that helps stakeholders identify potential investment opportunities. The report includes comprehensive details about both key and minor players in the market, supporting effective risk analysis and informed investment decisions. With accurate segmentation by end users and geographic regions, the report offers niche-level insights into specific market segments. Furthermore, it highlights critical trends, challenges, growth drivers, and opportunities, which contribute to a well-rounded strategic decision-making process.
Analysis of the key growth drivers, restraints, challenges, and opportunities influencing the market growth for the lab automation market.
Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.
Market Development: The report segments the lab automation market by region.
Market Diversification: New product launches, unexploited markets, recent developments, and investments in the lab automation market.